BASAK KANLILAR-RUIZ: Open Payments
NPI 1477066132 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 7 payments from 5 companies in 2025. Trend: 2023 $20 · 2024 $1,746 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $130 |
| ARGENX US, INC. | 2 | $125 |
| Amgen Inc. | 1 | $124 |
| Teva Pharmaceuticals USA, Inc. | 1 | $123 |
| EMD Serono, Inc. | 2 | $101 |
Products named: TREMFYA, VYVGART, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
